Citation 76089

SATTAR,EA: GALAL,AM: MOSSA,GS:. (1996). ANTITUMOR GERMACRANOLIDES FROM ANVILLEA GARCINII.. 59(4)

Citation Details

TitleANTITUMOR GERMACRANOLIDES FROM ANVILLEA GARCINII.
AuthorsSATTAR,EA: GALAL,AM: MOSSA,GS:
Year1996
Volume59
Issue4

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Anvillea garcini (ASTERACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PARTHENOLID-9-ONE
None
2
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
MEDICINAL FOLKLORE REPORTED FOR
NoneNone
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
ACTIVE
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
ACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLID-9-ONE
STRONG ACTIVITY
22Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
PARTHENOLIDE,9-ALPHA-HYDROXY:
None
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
STRONG ACTIVITY
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
STRONG ACTIVITY
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
STRONG ACTIVITY
27
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
WEAK ACTIVITY
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
32
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
WEAK ACTIVITY
33
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
WEAK ACTIVITY
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
WEAK ACTIVITY
37
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
WEAK ACTIVITY
38
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
39
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
40
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-ALPHA-HYDROXY:
ACTIVE
41Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
PARTHENOLIDE,9-BETA-HYDROXY:
None
42
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
STRONG ACTIVITY
43
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
STRONG ACTIVITY
44
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
45
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
STRONG ACTIVITY
46
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
47
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
STRONG ACTIVITY
48
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
WEAK ACTIVITY
49
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
WEAK ACTIVITY
50
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
51
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
52
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
WEAK ACTIVITY
53
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
54
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
55
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
56
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
WEAK ACTIVITY
57
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,9-BETA-HYDROXY:
ACTIVE
58Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
None
59
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
60
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
61
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
62
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
STRONG ACTIVITY
63
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
64
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
65
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
66
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
67
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
68
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
69
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
70
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
71
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
72
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
73
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
74
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
ACTIVE
75
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-BETA-HYDROXY:
WEAK ACTIVITY
76Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
None
77
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
78
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
79
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
80
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
81
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
82
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
83
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
84
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
WEAK ACTIVITY
85
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
86
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
87
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
WEAK ACTIVITY
88
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
89
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
ACTIVE
90
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
WEAK ACTIVITY
91
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
WEAK ACTIVITY
92
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PARTHENOLIDE,1-BETA-10-ALPHA-EPOXY-9-ALPHA-HYDROXY:
WEAK ACTIVITY
Show SPARQL Queries (1)